regulatory
confidence high
sentiment negative
materiality 0.65
Co-Diagnostics gets 180-day Nasdaq extension to meet $1 minimum bid rule
Co-Diagnostics, Inc.
- Additional 180-day grace period to regain compliance expires January 5, 2026.
- Failed to regain $1 bid compliance during initial 180-day period.
- Qualifies for extension by meeting all other Nasdaq Capital Market listing requirements.
- Intends to cure deficiency via reverse stock split if necessary.